Key result
Propofol did not significantly modify intrinsic myocardial contractility in normal hamsters or those with hypertrophic cardiomyopathy.
Why the study?
Does propofol affect intrinsic myocardial contractility in hamsters with hypertrophic cardiomyopathy compared to normal hamsters?
Does propofol affect intrinsic myocardial contractility in hamsters with hypertrophic cardiomyopathy compared to normal hamsters?
Propofol does not significantly modify intrinsic myocardial contractility in normal or cardiomyopathic hamsters in vitro, suggesting it may lack direct myocardial depressant effects in this setting.
Answers are grounded in this paper and cite their sources.
Propofol spares contractility in HCM models; leaves open relevance to clinical use in cardiomyopathy.
BACKGROUND: Propofol is a short-acting intravenous induction agent that induces cardiovascular depression but without significant effect on intrinsic myocardial contractility in various species. However, its effects on diseased myocardium remain unknown. METHODS: The effects of propofol (1, 3, and 10 micrograms.ml-1) on the intrinsic contractility of left ventricular papillary muscles from normal hamsters and those with hypertrophic cardiomyopathy (strain BIO 14.6, aged 6 months) were investigated in vitro (Krebs-Henseleit solution, 29 degrees C, pH 7.40, Ca++ 2.5 mmol.l-1, stimulation frequency 3/min). RESULTS: Cardiac hypertrophy (143 +/- 13%, P < 0.001) was observed in cardiomyopathic hamsters. The contractility of papillary muscles from hamsters with cardiomyopathy was less than that of controls, as shown by the decrease in maximum shortening velocity (-29%, P < 0.03) and active isometric force (-51%, P < 0.001). Propofol did not induce any significant effect on contraction, relaxation, and contraction-relaxation coupling under low and high loads in normal hamsters. The effects of propofol were not significantly different between normal hamsters and those with cardiomyopathy. A slight but significant increase in maximum unloaded shortening velocity was observed in cardiomyopathic hamsters at 3 micrograms.ml-1 (4 +/- 6%, P < 0.05) and 10 micrograms.ml-1 (7 +/- 6%, P < 0.05). CONCLUSIONS: Propofol did not modify intrinsic myocardial contractility in normal hamsters, and no significant differences were observed between normal and cardiomyopathic hamsters. These results may be useful because, unlike propofol, most anesthetics decrease myocardial contractility. Nevertheless, indirect cardiac effects of propofol may be more important than its direct cardiac effects in patients with impaired cardiac function.
No takes yet. Share an insight, caveat, or question.
Riou et al. (1995) studied Hypertrophic cardiomyopathy. Propofol vs. Normal hamsters was evaluated on Intrinsic contractility of left ventricular papillary muscles. Propofol did not significantly modify intrinsic myocardial contractility in normal hamsters or those with hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: